Analysis of Uveal Melanoma 5-Year Survival Rates by Medicaid Status: A Nationwide Analysis

References

• Chang AE, Karnell LH, Menck HR. The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on cancer and the American cancer Society. Cancer. 1998;83(8):1664–1678. doi:10.1002/(sici)1097-0142(19981015)83:8<1664:aid-cncr23>3.0.co;2-g
   PubMed Web of Science ®Google Scholar
• Bornfeld N, Biewald E, Bauer S, Temming P, Lohmann D, Zeschnigk M. The interdisciplinary diagnosis and treatment of intraocular tumors. Dtsch Arztebl Int. 2018;115(7):106–111. doi:10.3238/arztebl.2018.0106
   PubMed Web of Science ®Google Scholar
• Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118(9):1881–1885. doi:10.1016/j.ophtha.2011.01.040
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O. Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis. Expert Rev Gastroenterol Hepatol. 2017;11(2):183–189. doi:10.1080/17474124.2017.1259563
   PubMed Web of Science ®Google Scholar
• Del Valle JP, Fillmore NR, Molina G, et al. Socioeconomic disparities in pancreas cancer resection and survival in the Veterans Health Administration. Ann Surg Oncol. 2022;29(5):3194–3202. doi:10.1245/s10434-021-11250-0
   PubMed Web of Science ®Google Scholar
• Afshar N, English DR, Milne RL. Factors explaining socio-economic inequalities in cancer survival: a systematic review. Cancer Control. 2021;28:10732748211011956. doi:10.1177/10732748211011956
   Web of Science ®Google Scholar
• Exarchakou A, Kipourou DK, Belot A, Rachet B. Socio-economic inequalities in cancer survival: how do they translate into number of life-years lost? Br J Cancer. 2022;126(10):1490–1498. doi:10.1038/s41416-022-01720-x
   PubMed Web of Science ®Google Scholar
• Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:2819372. doi:10.1155/2017/2819372
   PubMed Web of Science ®Google Scholar
• Wiese D, Stroup AM, Maiti A, et al. Socioeconomic disparities in colon cancer survival: revisiting neighborhood poverty using residential histories. Epidemiology. 2020;31(5):728–735. doi:10.1097/EDE.0000000000001216
   PubMed Web of Science ®Google Scholar
• Role of occupation in shaping cancer disparities - PubMed. Accessed December 13, 2022. https://pubmed.ncbi.nlm.nih.gov/36077790/
   Google Scholar
• Bradley CJ, Gardiner J, Given CW, Roberts RC. Cancer, Medicaid enrollment, and survival disparities. Cancer. 2005;103(8):1712–1718. doi:10.1002/cncr.20954
   PubMed Web of Science ®Google Scholar
• Shildkrot Y, Thomas F, Al-Hariri A, Fry CL, Haik BG, Wilson MW. Socioeconomic factors and diagnosis of uveal melanoma in the mid-southern United States. Curr Eye Res. 2011;36(9):824–830. doi:10.3109/02713683.2011.593109
   PubMed Web of Science ®Google Scholar
• Rajeshuni N, Zubair T, Ludwig CA, Moshfeghi DM, Mruthyunjaya P. Evaluation of racial, ethnic, and socioeconomic associations with treatment and survival in Uveal melanoma, 2004-2014. JAMA Ophthalmol. 2020;138(8):876–884. doi:10.1001/jamaophthalmol.2020.2254
   PubMed Web of Science ®Google Scholar
• Abt NB, Miller LE, Parikh A, Bhattacharyya N. Insurance status effect on laryngeal cancer survival: a population based study. Ann Otol Rhinol Laryngol. 2022;131(7):775–781. doi:10.1177/00034894211044231
   PubMed Web of Science ®Google Scholar
• Zaydfudim V, Whiteside MA, Griffin MR, Feurer ID, Wright JK, Pinson CW. Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma. Ann Surg Oncol. 2010;17(12):3104–3111. doi:10.1245/s10434-010-1181-2
   PubMed Web of Science ®Google Scholar
• Wang J, Ha J, Lopez A, Bhuket T, Liu B, Wong RJ. Medicaid and uninsured hepatocellular carcinoma patients have more advanced tumor stage and are less likely to receive treatment. J Clin Gastroenterol. 2018;52(5):437–443. doi:10.1097/MCG.0000000000000859
   PubMed Web of Science ®Google Scholar
• Adler Jaffe S, Myers O, Meisner ALW, Wiggins CL, Hill DA, McDougall JA. Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival. Cancer Epidemiol Biomarkers Prev. 2020;29(2):300–307. doi:10.1158/1055-9965.EPI-19-0902
   PubMed Web of Science ®Google Scholar
• Naghavi AO, Echevarria MI, Grass GD, et al. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016;122(22):3529–3537. doi:10.1002/cncr.30212
   PubMed Web of Science ®Google Scholar
• Analysis of recent national trends in Medicaid and CHIP enrollment | KFF. Accessed July 19, 2022. https://www.kff.org/coronavirus-covid-19/issue-brief/analysis-of-recent-national-trends-in-medicaid-and-chip-enrollment/
   Google Scholar
• Warren JL, Benner S, Stevens J, et al. Development and evaluation of a process to link cancer patients in the SEER registries to National Medicaid Enrollment Data. JNCI Monogr. 2020;2020(55):89–95. doi:10.1093/jncimonographs/lgz035
   Google Scholar
• Aronow ME, Topham AK, Singh AD. Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013). Ocul Oncol Pathol. 2018;4(3):145–151. doi:10.1159/000480640
   PubMed Web of Science ®Google Scholar
• Laíns I, Bartosch C, Mondim V, et al. Second primary neoplasms in patients with uveal melanoma: a SEER database analysis. Am J Ophthalmol. 2016;165:54–64. doi:10.1016/j.ajo.2016.02.022
   PubMed Web of Science ®Google Scholar
• Zabor EC, Radivoyevitch T, Singh AD, et al. Conditional survival in Uveal melanoma. Ophthalmol Retina. 2021;5(6):536–542. doi:10.1016/j.oret.2020.09.015
   PubMedGoogle Scholar
• Affeldt JC, Minckler DS, Azen SP, Yeh L. Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol. 1980;98(11):1975–1979. doi:10.1001/archopht.1980.01020040827006
   PubMedGoogle Scholar
• Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. British J Ophthalmol. 1978;62(6):420–425. doi:10.1136/bjo.62.6.420
   PubMed Web of Science ®Google Scholar
• Singh AD, Zabor EC, Radivoyevitch T. Estimating cured fractions of Uveal melanoma. JAMA Ophthalmol. 2021;139(2):174–181. doi:10.1001/jamaophthalmol.2020.5720
   PubMed Web of Science ®Google Scholar
• Virnig BA. Associating insurance status with cancer stage at diagnosis. Lancet Oncol. 2008;9(3):189–191. doi:10.1016/S1470-2045(08)70043-3
   PubMed Web of Science ®Google Scholar
• Bradley CJ, Sabik LM, Entwistle J, Stevens JL, Enewold L, Warren JL. Role of Medicaid in early detection of screening-amenable cancers. Cancer Epidemiol Biomarkers Prev. 2022;31(6):1202–1208. doi:10.1158/1055-9965.EPI-21-1077
   PubMed Web of Science ®Google Scholar